Search
Proteomics managing director Richard Lipscombe.

Proteomics shares up more than 200%

Shares in Nedlands-based Proteomics International Laboratories skyrocketed on news it had produced and validated a predictive test for the diagnosis of diabetic kidney disease.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Total Shareholder Return as at 29/03/18

1 year TSR5 year TSR
153rdRBR67%-14%
214thFastbrick Robotics43%54%
327thProteomics International Laboratories18%0%
426thiSignthis0%140%
716 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

06/04/18
$0 Issued
06/04/18
$255k Issued
06/04/18
$255k Other
Total value as at the date of the transaction
Source: Morningstar

Revenue

130th↓Proteomics International Laboratories$1.8m
138th↑Fastbrick Robotics$1.3m
139th-RBR$1.3m
141st↑iSignthis$1.2m
142nd↓AnaeCo$1.2m
236 listed industrial companies ranked by revenue.
Source: Morningstar

Remuneration from Proteomics International Laboratories

395thRichard Lipscombe$325k
1149thJohn Dunlop$67k
1232ndTerry Sweet$55k
Ranked by total remuneration from all listed WA companies

BNiQ Disclaimer